Inventor · disambiguated record
Ekta Seth Chhabra
Also filed as: CHHABRA EKTA SETH
6 granted patents·11 pending applications·65 citations·filing 2013–2025
83Inventor score
Top patents by PatentIndex Score
17 records- 0194US10138291B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Nov 27, 2018·30 cites·36 claims
- 0293US11192936B2Factor VIII chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2015·Granted Dec 7, 2021·10 cites·58 claims
- 0393US11091534B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Aug 17, 2021·8 cites·20 claims
- 0489US10745680B2Factor IX fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Aug 18, 2020·6 cites·27 claims
- 0589US10548953B2Factor VIII-XTEN fusions and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Feb 4, 2020·6 cites·17 claims
- 0688US11370827B2Chimeric factor VIII polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Jun 28, 2022·5 cites·48 claims
- 0775US2024083975A1Thrombin cleavable linker with xten and its uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0870US2022275057A1Factor viii chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0970US2022056108A1Factor viii complex with xten and von willebrand factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1070US2024350672A1Nucleic acids encoding factor viii polypeptides with reduced immunogenicityBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1169US2025289869A1Factor viii chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1268US2022106383A1Thrombin cleavable linker with xten and its uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1368US2023011438A1Chimeric factor viii polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1459US2021032616A1Factor ix fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1557US2016251408A1Thrombin cleavable linker with xten and its uses thereofBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 1644US2016229903A1Thrombin cleavable linkerBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 1741US2021238259A1Factor ix fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →